XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
Condensed Consolidated Statements of Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Revenues $ 53,473 $ 54,287 $ 157,283 $ 163,489
Cost of revenues 20,071 21,522 60,589 62,997
Gross profit 33,402 32,765 96,694 100,492
Operating expense:        
Selling 9,737 8,437 28,363 27,660
General and administrative 19,438 16,129 55,024 54,543
Research and development 4,294 4,797 14,098 15,486
Total operating expense 33,469 29,363 97,485 97,689
Operating (loss) income (67) 3,402 (791) 2,803
Nonoperating expense:        
Interest expense and amortization of debt issuance costs 1,856 1,162 3,809 3,390
Other (income) expense, net (3,869) 324 (4,284) (475)
Total nonoperating (income) expense, net (2,013) 1,486 (475) 2,915
Earnings (loss) before income taxes 1,946 1,916 (316) (112)
Income tax (benefit) expense (170) 1,465 (653) (431)
Net (loss) income $ 2,116 $ 451 $ 337 $ 319
Earnings per share:        
Basic earnings per share (in dollars per share) $ 0.39 $ 0.08 $ 0.06 $ 0.06
Diluted earnings per share (in dollars per share) $ 0.39 $ 0.08 $ 0.06 $ 0.06
Weighted-average common shares outstanding:        
Basic (in shares) 5,393 5,339 5,384 5,312
Fully diluted shares (in shares) 5,396 5,360 5,394 5,354